LIGHTPATH TECHNOLOGIES INC-A (LPTH)

US5322578056 - Common Stock

1.42  -0.02 (-1.39%)

Fundamental Rating

2

Taking everything into account, LPTH scores 2 out of 10 in our fundamental rating. LPTH was compared to 127 industry peers in the Electronic Equipment, Instruments & Components industry. LPTH may be in some trouble as it scores bad on both profitability and health. LPTH is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year LPTH has reported negative net income.
In the past year LPTH has reported a negative cash flow from operations.
In the past 5 years LPTH reported 4 times negative net income.
LPTH had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -9.29%, LPTH is doing worse than 68.25% of the companies in the same industry.
LPTH's Return On Equity of -14.91% is on the low side compared to the rest of the industry. LPTH is outperformed by 63.49% of its industry peers.
Industry RankSector Rank
ROA -9.29%
ROE -14.91%
ROIC N/A
ROA(3y)-6.8%
ROA(5y)-4.88%
ROE(3y)-10.89%
ROE(5y)-7.63%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LPTH's Gross Margin of 31.15% is in line compared to the rest of the industry. LPTH outperforms 53.97% of its industry peers.
LPTH's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for LPTH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.3%
GM growth 5Y-2.69%

2

2. Health

2.1 Basic Checks

LPTH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LPTH has been increased compared to 1 year ago.
LPTH has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LPTH has an improved debt to assets ratio.

2.2 Solvency

LPTH has an Altman-Z score of -3.37. This is a bad value and indicates that LPTH is not financially healthy and even has some risk of bankruptcy.
LPTH's Altman-Z score of -3.37 is on the low side compared to the rest of the industry. LPTH is outperformed by 84.13% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that LPTH is not too dependend on debt financing.
The Debt to Equity ratio of LPTH (0.02) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -3.37
ROIC/WACCN/A
WACC9.16%

2.3 Liquidity

LPTH has a Current Ratio of 1.93. This is a normal value and indicates that LPTH is financially healthy and should not expect problems in meeting its short term obligations.
LPTH's Current ratio of 1.93 is on the low side compared to the rest of the industry. LPTH is outperformed by 62.70% of its industry peers.
A Quick Ratio of 1.16 indicates that LPTH should not have too much problems paying its short term obligations.
LPTH's Quick ratio of 1.16 is on the low side compared to the rest of the industry. LPTH is outperformed by 73.81% of its industry peers.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.16

4

3. Growth

3.1 Past

LPTH shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.67%.
The Revenue has decreased by -1.74% in the past year.
LPTH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.24% yearly.
EPS 1Y (TTM)6.67%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-66.67%
Revenue 1Y (TTM)-1.74%
Revenue growth 3Y-1.98%
Revenue growth 5Y0.24%
Revenue growth Q2Q-13.63%

3.2 Future

Based on estimates for the next years, LPTH will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.89% on average per year.
LPTH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.02% yearly.
EPS Next Y-15.08%
EPS Next 2Y14.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.75%
Revenue Next 2Y10.02%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LPTH. In the last year negative earnings were reported.
Also next year LPTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as LPTH's earnings are expected to grow with 14.89% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.89%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LPTH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LIGHTPATH TECHNOLOGIES INC-A

NASDAQ:LPTH (5/3/2024, 7:04:04 PM)

1.42

-0.02 (-1.39%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap53.99M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.29%
ROE -14.91%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 31.15%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.93
Quick Ratio 1.16
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)6.67%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-15.08%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.74%
Revenue growth 3Y-1.98%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y